SCWTF yields 5.70% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, SCWTF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SCWTF + PFE for your $10,000?
Schweiter Technologies AG engages in the development, production, and distribution of extruded and cast plastic sheets, composite panels, and core materials for composite structures in Europe, the Americas, Asia, and internationally. The company offers new generation for traffic signs made from aluminum composite panels; decorative façade material and innovative roof cladding made from aluminum composite panels; individual photo wall, printed on lightweight foam sheets; and cycle shelter with optimum weather protection from extruded acrylic sheets. It also provides lightweight composite elements for buses and coaches; lightweight chassis for city buses; high-quality baths and basins from thermoformed acrylic sheets; mats and balance pads for the fitness/sports and physio market; PET rigid foams for wind farm components; structural balsa wood for wind farm components; and greenhouse made of virtually unbreakable extruded multiwall polycarbonate sheets. The company serves the display, architecture, wind energy, marine, transportation, and industrial markets. It offers its products under the AIREX, ALUCOBOND, BALTEK, DIBOND, FOREX, GATOR, KAPA, PERSPEX, SINTRA, CRYLON, and CRYLUX brands. In addition, it is involved in the property management and management activities. The company was founded in 1912 and is headquartered in Steinhausen, Switzerland.
Full SCWTF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.